Although millions of lives have been saved by new biomedical technologies and expansion of prevention and treatment in low- and middle-income countries, many vulnerable people ? including in the US ? are not benefiting from these advances. Implementation science (IS) research can maximize public health impact by addressing suboptimal implementation of evidence-based strategies; identifying ways in which health care systems and policies fail to adequately address the HIV prevention and care continua; and identifying population-based strategies to improve HIV outcomes in the US and globally. The Implementation Science and Health Outcomes (ISHO) Core will address the HIV Center's overall theme by catalyzing innovative IS research that identifies and tests strategies to optimize ?real-world? uptake and impact of effective HIV prevention and care continua interventions at scale. The Core has three Specific Aims: (1) to stimulate new IS research and collaborations to improve key outcomes along the HIV prevention and care continua; (2) to advance new IS research to prevent or reduce HIV-related health disparities that are driven by suboptimal intervention implementation or by psychiatric and other comorbidities; and (3) to promote the use of health policy analysis, policy modeling, and economic evaluation to bridge the evidence-practice and evidence-policy gaps that drive suboptimal population-based implementation and disparities. The ISHO Core will accomplish its Aims through functions that include (1) providing expert consultation to HIV Center researchers on conducting IS research that (a) both tests new approaches to improve HIV-related programmatic outcomes and assesses causes of successful and un-successful implementation of interventions and policies at scale, and (b) incorporates the perspectives of policy translation, policy modeling, and economic evaluation into their research; (2) developing Scientific Working Groups to provide structured and focused guidance to (and collaboration with) Center investigators interested in or embarking on IS through dynamic small groups organized around specific themes (e.g., PrEP implementation, psychiatric comorbidities); (3) facilitating access to linked networks for HIV Center investigators addressing IS-related research questions; and (4) sponsoring seminars to stimulate the use of IS approaches in research. The proposed Core Director, Denis Nash, Ph.D., is an epidemiologist and Director of the Institute for Implementation Science in Population Health (ISPH) at the City University of New York. Core Co-Director, Milton Wainberg, M.D., is a research psychiatrist at the New York State Psychiatric Institute and Columbia University Department of Psychiatry. Together they have extensive expertise in NIH-funded research and capacity building for HIV and mental health treatment and prevention. The Core brings together early stage, mid-career, and established investigators in the areas of IS, health-disparities, and economic evaluation with policy-makers and program implementers to provide an infrastructure for research collaboration.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Center Core Grants (P30)
Project #
5P30MH043520-32
Application #
9873087
Study Section
Special Emphasis Panel (ZMH1)
Project Start
Project End
Budget Start
2020-02-01
Budget End
2021-01-31
Support Year
32
Fiscal Year
2020
Total Cost
Indirect Cost
Name
New York State Psychiatric Institute
Department
Type
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Winhusen, Theresa; Feaster, Daniel J; Duan, Rui et al. (2018) Baseline Cigarette Smoking Status as a Predictor of Virologic Suppression and CD4 Cell Count During One-Year Follow-Up in Substance Users with Uncontrolled HIV Infection. AIDS Behav 22:2026-2032
Meyers, Kathrine; Wu, Yumeng; Qian, Haoyu et al. (2018) Interest in Long-Acting Injectable PrEP in a Cohort of Men Who have Sex with Men in China. AIDS Behav 22:1217-1227
Bauermeister, José A; Giguere, R; Leu, C S et al. (2018) Patterns of a Rectal Microbicide Placebo Gel Use in a Preparatory Stage for a Phase I Trial Among Young Men Who Have Sex with Men. AIDS Behav 22:412-420
Fogel, Jessica M; Sandfort, Theodorus; Zhang, Yinfeng et al. (2018) Accuracy of Self-Reported HIV Status Among African Men and Transgender Women Who Have Sex with Men Who were Screened for Participation in a Research Study: HPTN 075. AIDS Behav :
Davis, Alissa; McCrimmon, Tara; Dasgupta, Anindita et al. (2018) Individual, social, and structural factors affecting antiretroviral therapy adherence among HIV-positive people who inject drugs in Kazakhstan. Int J Drug Policy 62:43-50
Carballo-Dieguez, Alex; Giguere, Rebecca; Lentz, Cody et al. (2018) Rectal Douching Practices Associated with Anal Intercourse: Implications for the Development of a Behaviorally Congruent HIV-Prevention Rectal Microbicide Douche. AIDS Behav :
Fifield, Jocelyn; O'Sullivan, Lucia; Kelvin, Elizabeth A et al. (2018) Social Support and Violence-prone Relationships as Predictors of Disclosure of HIV Status Among Newly Diagnosed HIV-positive South Africans. AIDS Behav :
Wainberg, Milton L; McKinnon, Karen; Norcini-Pala, Andrea et al. (2018) Ending AIDS as a Public Health Threat: Treatment-as-Usual Risk Reduction Services for Persons With Mental Illness in Brazil. Psychiatr Serv 69:483-486
Tariq, Shema; Hoffman, Susie; Ramjee, Gita et al. (2018) ""I did not see a need to get tested before, everything was going well with my health"": a qualitative study of HIV-testing decision-making in KwaZulu-Natal, South Africa. AIDS Care 30:32-39
Giguere, Rebecca; Brown III, William; Balán, Ivan C et al. (2018) Are participants concerned about privacy and security when using short message service to report product adherence in a rectal microbicide trial? J Am Med Inform Assoc 25:393-400

Showing the most recent 10 out of 714 publications